Market Research Logo

Global Neuromodulation Market - Segmented by Technology, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Global Neuromodulation Market - Segmented by Technology, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)

The global neuromodulation market is expected to register a CAGR of about 14%, over the forecast period, 2018-2023. Neuromodulators are a subset of neurotransmitter. Unlike neurotransmitters, the release of neuromodulators occurs in a diffuse manner. This means that an entire neural tissue may be subject to the neuromodulator’s action due to exposure. This, in turn, can tune the neural circuitry of an entire brain region; not just that of an individual neuron.

Increase in the Aging Population to Fuel Market Growth

Neurological diseases are frequent in older adults, affecting around 55% of people age 55 and older. They are associated with a high risk for adverse health outcomes, including mortality, disability, institutionalization, and hospitalization. Degenerative diseases, like dementia and Parkinson’s disease, as well as strokes and headaches are frequently encountered neurological diseases in elderly patients. Neuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment of the neurological most of the diseases, like bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most commonly found in the elderly population. The proven efficacy and improving acceptance of this technology will lead to the surge in the market size during the forecast period. Other factors that will affect the growth of the market positively include rising prevalence of neurological disorders to spur market growth, strong product pipeline to propel the market, expanded target applications and new indications are expected to stimulate the growth of neuromodulation devices and investments and funds.

Inconsistent Reimbursement Policies Due to Lack of Practice Guide Lines

The lack of practice guidelines is a barrier to consistent application of the technology in practice, coverage, and reimbursement decisions. Without such guidelines, clinical decisions may be based on the opinions of independent practitioners who may or may not have experience with a technology and health plans setting coverage policy. Inconsistent reimbursement decisions may limit patient access to treatment and business development. This will also translate into slowdown of the growth of the neuromodulation market. Other factors that will act as restraints for the market include, lack of trained professionals likely to hamper market growth.

North America to Maintain Dominance

North America is the most attractive market in the neuromodulation industry and is estimated to be the first preference for new entrants due to the increasing faith in the technology and end-use in the region. Asia-Pacific is the fastest growing market; hence the established players are focusing on the region.

Key Developments in the Market:

  • August 2017 - FDA Clears Xavant Technology's Stimpod NMS460 Non-Invasive NeuromodulationDevice for Treatment of Chronic Intractable Pain
Major Players: BIOCONTROL MEDICAL, BOSTON SCIENTIFIC CORPORATION, CYBERONICS, INC., MEDTRONIC, INC., NEURONETICS, INC., NEUROPACE, INC., NEUROSIGMA, INC., NEVRO CORPORATION, ST. JUDE MEDICAL, INC. AND SYNAPSE BIOMEDICAL, INC., amongst others.

Reasons to Purchase the Report
  • Current and future neuromodulation market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in Excel)
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.


1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rising Prevalence of Neurological Disorders to Spur Market Growth
6.1.2 Increase in the Aging Population to Fuel Market Growth
6.1.3 Strong Product Pipeline to Propel the Market
6.1.4 Expanded Target Applications and New Indications are Expected to Stimulate the Growth of Neuromodulation Devices
6.1.5 Investments and Funds
6.2 Market Restraints
6.2.1 Inconsistent Reimbursement Policies Due to Lack of Practice Guide Lines
6.2.2 Lack of Trained Professionals Likely to Hamper Market Growth
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Technology
7.1.1 Internal Neuromodulation
7.1.1.1 Spinal Cord Stimulation (SCS)
7.1.1.2 Deep Brain Stimulation (DBS)
7.1.1.3 Vagus Nerve Stimulation (VNS)
7.1.1.4 Sacral Nerve Stimulation (SNS)
7.1.1.5 Gastric Electrical Stimulation (GES)
7.1.2 External Neuromodulation (Non-Invasive)
7.1.2.1 Transcutaneous Electrical Nerve Stimulation (Tens)
7.1.2.2 Transcranial Magnetic Stimulation (TMS)
7.1.2.3 Respiratory Electrical Stimulation (RES)
7.2 By Application
7.2.1 Spinal Cord Stimulation (SCS) Market, By Application
7.2.2 Deep Brain Stimulation (DBS) Market, By Application
7.2.3 Sacral Nerve Stimulation Market, By Application
7.2.4 Vagus Nerve Stimulation Market, By Application
7.2.5 Gastric Electrical Stimulation Market, By Application
7.2.6 Transcutaneous Electrical Nerve Stimulation Market, By Application
7.2.7 Repetitive Transcranial Magnetic Stimulation Market, By Application
7.2.8 Respiratory Electrical Stimulation Market, By Application
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 India
7.3.3.2 Australia & New Zealand
7.3.3.3 South Korea
7.3.3.4 Rest of Asia-Pacific
7.3.4 Rest of World
7.3.4.1 Saudi Arabia
7.3.4.2 Brazil
7.3.4.3 Others
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Biocontrol Medical
9.2 Boston Scientific Corporation
9.3 Cyberonics, Inc.
9.4 Medtronic, Inc.
9.5 Neuronetics, Inc.
9.6 Neuropace, Inc.
9.7 Neurosigma, Inc.
9.8 Nevro Corporation
9.9 ST. Jude Medical, Inc.
9.10 Synapse Biomedical, Inc.
*List Not Exhaustive
10. Future of the Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report